Back

Prognostic value of neutrophil-to-lymphocyte ratio and cardiac troponin I in patients with immune checkpoint inhibitors-related myocarditis

1 September 2024 (07:55 - 08:40)
Organised by: Logo
Congress Presentation Part of: Cardiovascular primary care: taking comorbidities into account Cardio-Oncology ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Tong Liu

2nd Hospital of Tianjin Medical University, Tianjin (China)

5 More presentations in this session

Presentation thumbnail
LDL-C target attainment and statin use in patients with ASCVD, familial hypercholesterolaemia, and those otherwise at moderate/high-risk of ASCVD in australian general practice (SCOPE-GP)
Ms C. Sciascia (AU)
Abstract Slides Video
Presentation thumbnail
Utility of the triglycerides/HDL cholesterol ratio in older adult patients in colombia.
Miss C. Murgueitio Guzman (Bogota, CO)
Abstract Slides Video
Presentation thumbnail
Modifiable risk factors and incident cardiovascular events in gout patients
Doctor C. Zhao (CN)
Abstract Slides Video
Presentation thumbnail
Cardiovascular emergency in indonesian primary health care (PUSKESMAS): a national multicentre service evaluation study based on ESC guidelines adherence
Mr C. Multazam (Manchester, GB)
Abstract Slides Video
Presentation thumbnail
Clinical profile and outcomes of patients with chronic kidney disease on chronic hemodialysis hospitalized for acute coronary syndrome in a tertiary public hospital in the Philippines
Doctor J. Mapili (Manila, PH)
Abstract Slides Video

Access the full session

Session thumbnail
Cardiovascular primary care: taking comorbidities into account

The Event

Event poster

ESC Congress 2024

1 September 2024 07:55 CET
You may be interested in
thumbnail
Congress Presentation
Cardiac magnetic resonance imaging for diagnosis and prognosis of patients with myocarditis from immune checkpoint inhibitor therapy: a meta-analysis
thumbnail
Congress Presentation
The predictive value of routine troponin measurements in patients treated with immune checkpoint inhibitors
thumbnail
Congress Presentation
Immune checkpoint inhibitor myocarditis

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources